Naoxintong Capsule

Developed for: ischemic stroke
Investigated by: Shanghai Municipal Science and Technology Commission · Xiaofei Yu

today NCT02334969 · Ph 4

201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT02334969	Apr 2016 → Aug 2018	ischemic stroke	Xiaofei Yu	Completed	Met primary

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Naoxintong Capsule	ClinicalTrials.gov intervention name — accepted as the source's own label NCT02334969 ↗
Route	Oral	“Naoxintong Capsule (1.2 g orally, twice a day)” PMID 36251140 ↗ Oct 2022